Trials / Terminated
TerminatedNCT00986856
Fucidin® Cream in the Treatment of Impetigo
A Phase IV Study Comparing Clinical and Bacteriological Efficacy of Fucidin® Cream With Fucidin® Cream Vehicle in the Treatment of Impetigo in Paediatric Patients
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 2 Years – 11 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the clinical and bacteriological efficacy of Fucidin® cream in the treatment of impetigo in paediatric patients. To assess the validity of in vitro susceptibility-testing of S. aureus to fusidic acid as a prediction of clinical and bacteriological outcome in impetigo patients treated with Fucidin® cream. To investigate the genetic relationship between S. aureus-strains isolated from impetigo patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fucidin® cream |
Timeline
- Start date
- 2004-05-01
- Primary completion
- 2005-03-01
- Completion
- 2005-03-01
- First posted
- 2009-09-30
- Last updated
- 2025-03-06
- Results posted
- 2010-09-29
Locations
2 sites across 2 countries: Norway, Sweden
Source: ClinicalTrials.gov record NCT00986856. Inclusion in this directory is not an endorsement.